Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 7,800.00
-140.00 (-1.76%)
At close: Aug 24, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 65.66 billion as of August 24, 2026. Its market cap has decreased by -30.66% in one year.
Market Cap
65.66B
Enterprise Value
-23.93B
Revenue
107.87B
Ranking
n/a
PE Ratio
16.44
Stock Price
7,800.00
ChartMarket Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 65.66B, an increase of 166.09%. That is a compound annual growth rate of 4.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 65.66B | -32.42% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 85.75B |
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Daehan Nupharm | 78.32B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 66.97B |
| Sinsin Pharmaceutical | 66.30B |
| Sinil Pharmaceutical | 66.21B |